Baxter International Inc.

BAX Healthcare Medical Instruments & Supplies

Baxter International Inc.’s revenue for fiscal 2025 (year ended December 2025) was $11.2 billion, up 5.72% from fiscal 2024. In the quarter to June 2026, revenue grew 5.34%, EPS grew 33.3%, free cash flow grew 119.5% and total debt was flat, each against the same quarter a year earlier. Member of the S&P 500; revenue growth for three consecutive years.

25.33 0.43 −1.67%
Market cap
$13.3B
P/E
0.0×
Fwd P/E
44.7×
Dividend yield
0.16%
F-score
4/9
Altman Z
2.12
Beneish M
−2.67
Dividend safety
0/100

Baxter International Inc. (BAX) Free cash flow

Alert me on Free cash flow

Baxter International Inc.'s free cash flow for fiscal 2025 was $332.0M, down 42.1% from $573.0M in fiscal 2024. Over the twelve months to 30 June 2026 it was $815.0M. Over the past ten years it has ranged from $332.0M (fiscal 2025) to $1.5B (fiscal 2021) — the current reading is the lowest in ten years. Baxter International Inc. ranks 6th of 54 Medical Instruments & Supplies companies by free cash flow.

Free cash flow, annual

Embed this chart

Annual newest first

Period Free cash flow Change
FY2025 $332.0M (42.06%)
FY2024 $573.0M (55.72%)
FY2023 $1.3B 55.16%
FY2022 $834.0M (45.53%)
FY2021 $1.5B 32.10%
FY2020 $1.2B (17.68%)
FY2019 $1.4B 3.68%
FY2018 $1.4B 23.68%
FY2017 $1.1B 17.43%
FY2016 $935.0M 8.72%

Quarterly newest first

Period Free cash flow Change
Jun 2026 $169.0M 122.37%
Mar 2026 $76.0M (82.88%)
Dec 2025 $444.0M 252.38%
Sep 2025 $126.0M 63.64%
42 more quarters

Against its own ten years

Low $332.0M High $1.5B
Ten-year median $1.1B
Current reading's percentile 9

Free cash flow against peers

What Free cash flow is

Free Cash Flow tells an investor how much cash a company’s operations generate after paying for its investment in physical and intangible assets.

Operating Cash Flow + Property, Plant, Equipment Change (Net) + Intangible Assets Change (Net)

The full definition of Free cash flow →

More on BAX